AGREEMENT
EXHIBIT A
AGREEMENT
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of AN2 Therapeutics, Inc.
| Date: April 10, 2024 | XXXXXXX LIFE SCIENCES PUBLIC FUND, L.P. | |||||
| By: FHMLSP, L.P., its General Partner | ||||||
| By: FHMLSP, L.L.C., its General Partner | ||||||
| By: /s/ Xxxxx X. Xxxxxx | ||||||
| Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
| Date: April 10, 2024 | FHMLSP, L.P. | |||||
| By: FHMLSP, L.L.C., its General Partner | ||||||
| By: /s/ Xxxxx X. Xxxxxx | ||||||
| Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
| Date: April 10, 2024 | FHMLSP, L.L.C. | |||||
| By: /s/ Xxxxx X. Xxxxxx | ||||||
| Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
| Date: April 10, 2024 | XXXXXXX LIFE SCIENCES PUBLIC OVERAGE FUND, L.P. | |||||
| By: FHMLSP Overage, L.P., its General Partner | ||||||
| By: FHMLSP Overage, L.L.C., its General Partner | ||||||
| By: /s/ Xxxxx X. Xxxxxx | ||||||
| Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
| Date: April 10, 2024 | FHMLSP OVERAGE, L.P. | |||||
| By FHMLSP Overage, L.L.C., its General Partner | ||||||
| By: /s/ Xxxxx X. Xxxxxx | ||||||
| Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
| Date: April 10, 2024 | FHMLSP OVERAGE, L.L.C. | |||||
| By: /s/ Xxxxx X. Xxxxxx | ||||||
| Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
| Date: April 10, 2024 | XXXXXXX LIFE SCIENCES XI, L.P. | |||||
| By: FHMLS XI, L.P., its General Partner | ||||||
| By: FHMLS XI, L.L.C., its General Partner | ||||||
| By: /s/ Xxxxx X. Xxxxxx | ||||||
| Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
| Date: April 10, 2024 | FHMLS XI, L.P. | |||||
| By: FHMLS XI, L.L.C., its General Partner | ||||||
| By: | /s/ Xxxxx X. Xxxxxx | |||||
| Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
| Date: April 10, 2024 | FHMLS XI, L.L.C. | |||||
| By: | /s/ Xxxxx X. Xxxxxx | |||||
| Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
| Date: April 10, 2024 | XXXXXXX LIFE SCIENCES X, L.P. | |||||
| By: FHMLS X, L.P., its General Partner | ||||||
| By: FHMLS X, L.L.C., its General Partner | ||||||
| By: | /s/ Xxxxx X. Xxxxxx | |||||
| Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
| Date: April 10, 2024 | FHMLS X, L.P. | |||||
| By: FHMLS X, L.L.C., its General Partner | ||||||
| By: | /s/ Xxxxx X. Xxxxxx | |||||
| Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
| Date: April 10, 2024 | FHMLS X, L.L.C. | |||||
| By: | /s/ Xxxxx X. Xxxxxx | |||||
| Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
| Date: April 10, 2024 | By: | * | ||||
| Xxxxx X. Xxxxxx | ||||||
| Date: April 10, 2024 | By: | * | ||||
| Xxxxxxx X. Xxxxx | ||||||
| Date: April 10, 2024 | By: | ** | ||||
| Xxxxxx Xxx | ||||||
| Date: April 10, 2024 | By: | ** | ||||
| Xxxxx Xxxxx | ||||||
| Date: April 10, 2024 | By: | *** | ||||
| Xxxxxx Xxxxx | ||||||
| Date: April 10, 2024 | By: | /s/ Xxxxx X. Xxxxxx | ||||
| Xxxxx X. Xxxxxx, as Attorney-in-Fact | ||||||
| * | This Agreement was executed by Xxxxx X. Xxxxxx on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on March 29, 2016. |
| ** | This Agreement was executed by Xxxxx X. Xxxxxx on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on August 16, 2021. |
| *** | This Agreement was executed by Xxxxx X. Xxxxxx on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on April 18, 2022. |
